• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.小胰腺神经内分泌肿瘤(<2 cm)的标准胰腺切除术与保留实质切除术的肿瘤学和手术结果比较:Pancreas2000研究与教育项目(课程9)研究方案。
Front Med (Lausanne). 2020 Sep 10;7:559. doi: 10.3389/fmed.2020.00559. eCollection 2020.
2
Conservative management and parenchyma-sparing resections of pancreatic neuroendocrine tumors: Literature review.胰腺神经内分泌肿瘤的保守治疗和保留实质的切除术:文献回顾。
Int J Surg. 2015 Sep;21 Suppl 1:S10-4. doi: 10.1016/j.ijsu.2015.04.089. Epub 2015 Jun 26.
3
Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas Registry.德国外科界对当前欧洲神经内分泌肿瘤学会(ENETS)关于小(≤2厘米)胰腺神经内分泌肿瘤手术指南的实施情况:对前瞻性德国胰腺外科学会(DGAV)StuDoQ|胰腺登记处的分析
World J Surg. 2019 Jan;43(1):175-182. doi: 10.1007/s00268-018-4751-2.
4
Pre- and intraoperative diagnostic requirements, benefits and risks of minimally invasive and robotic surgery for neuroendocrine tumors of the pancreas.胰腺神经内分泌肿瘤的微创和机器人手术的术前和术中诊断要求、获益和风险。
Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101294. doi: 10.1016/j.beem.2019.101294. Epub 2019 Jul 10.
5
[Surgery of pancreatic neuroendocrine neoplasms: state of the art].[胰腺神经内分泌肿瘤的外科治疗:现状]
Chirurgie (Heidelb). 2022 Aug;93(8):745-750. doi: 10.1007/s00104-022-01641-8. Epub 2022 May 2.
6
Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).无功能性胰腺神经内分泌肿瘤(NF-PanNETs)中淋巴结受累的模式和临床预测因素。
JAMA Surg. 2013 Oct;148(10):932-9. doi: 10.1001/jamasurg.2013.3376.
7
Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.胰腺神经内分泌肿瘤(panNETs):非手术治疗与手术切除的总生存期分析
J Gastrointest Surg. 2017 May;21(5):855-866. doi: 10.1007/s11605-017-3365-6. Epub 2017 Mar 2.
8
Pancreatic neuroendocrine tumors: Preoperative factors that predict lymph node metastases to guide operative strategy.胰腺神经内分泌肿瘤:预测淋巴结转移以指导手术策略的术前因素。
J Surg Oncol. 2016 Sep;114(4):440-5. doi: 10.1002/jso.24338. Epub 2016 Jun 22.
9
Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.晚期神经内分泌肿瘤患者进行积极手术切除的发病率和死亡率。
Arch Surg. 2003 Aug;138(8):859-66. doi: 10.1001/archsurg.138.8.859.
10
Parenchyma-sparing resections for pancreatic neoplasms.胰腺肿瘤的保留胰腺实质切除术。
J Hepatobiliary Pancreat Sci. 2010 Nov;17(6):782-7. doi: 10.1007/s00534-009-0224-1. Epub 2009 Oct 29.

引用本文的文献

1
Parenchymal Sparing Resection: Options in Duodenal and Pancreatic Surgery.保留实质组织切除术:十二指肠和胰腺手术中的选择
J Clin Med. 2021 Apr 2;10(7):1479. doi: 10.3390/jcm10071479.

本文引用的文献

1
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States.美国神经内分泌肿瘤患者的发病率、患病率和生存结局趋势。
JAMA Oncol. 2017 Oct 1;3(10):1335-1342. doi: 10.1001/jamaoncol.2017.0589.
2
ENETS Consensus Guidelines for Standard of Care in Neuroendocrine Tumours: Surgery for Small Intestinal and Pancreatic Neuroendocrine Tumours.神经内分泌肿瘤护理标准的ENETS共识指南:小肠和胰腺神经内分泌肿瘤的手术治疗
Neuroendocrinology. 2017;105(3):255-265. doi: 10.1159/000464292. Epub 2017 Feb 25.
3
Observational study of natural history of small sporadic nonfunctioning pancreatic neuroendocrine tumors.散发性无功能性小胰腺神经内分泌肿瘤自然史的观察性研究。
J Clin Endocrinol Metab. 2013 Dec;98(12):4784-9. doi: 10.1210/jc.2013-2604. Epub 2013 Sep 20.
4
Pattern and clinical predictors of lymph node involvement in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs).无功能性胰腺神经内分泌肿瘤(NF-PanNETs)中淋巴结受累的模式和临床预测因素。
JAMA Surg. 2013 Oct;148(10):932-9. doi: 10.1001/jamasurg.2013.3376.
5
Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.体积小、无功能、无症状的胰腺神经内分泌肿瘤(PNET):非手术治疗的作用。
Surgery. 2012 Dec;152(6):965-74. doi: 10.1016/j.surg.2012.08.038. Epub 2012 Oct 24.
6
Parenchyma-sparing resections for pancreatic neuroendocrine tumors.保留胰腺实质的胰腺神经内分泌肿瘤切除术。
J Gastrointest Surg. 2012 Nov;16(11):2045-55. doi: 10.1007/s11605-012-2002-7. Epub 2012 Aug 22.
7
Tumor size correlates with malignancy in nonfunctioning pancreatic endocrine tumor.肿瘤大小与无功能性胰腺内分泌肿瘤的恶性程度相关。
Surgery. 2011 Jul;150(1):75-82. doi: 10.1016/j.surg.2011.02.022.
8
Parenchyma-preserving resections for small nonfunctioning pancreatic endocrine tumors.保留胰腺实质的小型无功能性胰腺内分泌肿瘤切除术。
Ann Surg Oncol. 2010 Jun;17(6):1621-7. doi: 10.1245/s10434-010-0949-8. Epub 2010 Feb 17.
9
Duodenum- and spleen-preserving total pancreatectomy for end-stage chronic pancreatitis.保留十二指肠和脾脏的全胰切除术治疗终末期慢性胰腺炎。
Br J Surg. 2003 Nov;90(11):1401-8. doi: 10.1002/bjs.4324.
10
Cytological differentiation of asymptomatic pancreatic islet cell tumours in autopsy material.尸检材料中无症状胰岛细胞瘤的细胞分化
Virchows Arch A Pathol Anat Histol. 1975;365(4):275-88. doi: 10.1007/BF00471177.

小胰腺神经内分泌肿瘤(<2 cm)的标准胰腺切除术与保留实质切除术的肿瘤学和手术结果比较:Pancreas2000研究与教育项目(课程9)研究方案。

Comparison of Oncological and Surgical Outcomes Between Formal Pancreatic Resections and Parenchyma-Sparing Resections for Small PanNETs (<2 cm): Pancreas2000 Research and Educational Program (Course 9) Study Protocol.

作者信息

Pea Antonio, Tanno Lulu, Nykänen Taina, Prasad Pooja, Tunçer Ceren, Robinson Stuart, Marchegiani Giovanni

机构信息

Department of Surgery, Istituto Pancreas, Ospedale Universitario Integrato Verona, Verona, Italy.

Department of General Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.

出版信息

Front Med (Lausanne). 2020 Sep 10;7:559. doi: 10.3389/fmed.2020.00559. eCollection 2020.

DOI:10.3389/fmed.2020.00559
PMID:33015105
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7511698/
Abstract

Pancreatic neuroendocrine tumors (PanNETs) are rare tumors but incidence is increasing. An increasing number of these tumors are diagnosed incidentally when they are small (<2 cm) and when patients are asymptomatic. The European Neuroendocrine Tumor Society (ENETS) recommends conservative watch and wait policy for these patients. However, best surgical approach (parenchyma-sparing or formal oncological resection) for these small tumors when surgery is indicated is currently unknown. Parenchyma-sparing resections such as enucleation is associated with higher risk of post-operative morbidity compared to formal oncological resections. They are also be associated with potentially inadequate surgical margin clearance and with lack of lymphadenectomy for full pathological staging. This study is a retrospective study and the aim is to analyze pre-operative clinical predictors of nodal metastases for small PanNETs to identify which patients are at a lower risk of lymph node metastases and are therefore suitable for parenchyma-sparing resection. The primary endpoint of this study is to determine if pre-operative clinical predictors such as tumor size are associated with lymph node involvement in small PanNETs.

摘要

胰腺神经内分泌肿瘤(PanNETs)是罕见肿瘤,但发病率正在上升。越来越多的此类肿瘤在体积较小(<2厘米)且患者无症状时被偶然诊断出来。欧洲神经内分泌肿瘤学会(ENETS)建议对这些患者采取保守的观察等待策略。然而,对于这些需要手术治疗的小肿瘤,目前尚不清楚最佳的手术方式(保留实质或正规肿瘤切除)是什么。与正规肿瘤切除相比,诸如剜除术等保留实质的切除术术后并发症风险更高。它们还可能与手术切缘清除不充分以及缺乏用于全面病理分期的淋巴结清扫有关。本研究是一项回顾性研究,目的是分析小PanNETs淋巴结转移的术前临床预测因素,以确定哪些患者发生淋巴结转移的风险较低,因此适合保留实质的切除术。本研究的主要终点是确定肿瘤大小等术前临床预测因素是否与小PanNETs的淋巴结受累有关。